CBCV (Cannabichromevarin) is the short-chain homologue of CBC, the least researched of the five major cannabinoids (including THC, CBD, CBG, CBN). It is the activated form of CBCVA, after decarboxylation, typically with heat or light.
CBCVA is synthesized from CBGVA, the short-chain homologue of cannabis’ main mother cannabinoid, CBGA. CBCVA and CBCV occur at very small concentrations naturally and remain federally illegal so very little is available for study.
Potential Uses & Benefits
CBC is currently being studied for its potential to fight tumors, acne, and Crohn’s, and may have significant synergistic qualities due to its ability to bind to receptors outside of the classic cannabinoid system.
A synthesis product of CBGA alongside THCA and CBDA, CBCA is produced in relatively-low quantities in most hemp and marijuana strains. CBCA and CBC occur most prevalent in marijuana strains grown in the tropics.